Table 4.
Summary of the DVH analysis for the organs at risk for the entire cohort of patients
| Organ | Volume (cm 3 ) | Parameter | Mean ± SD | Range |
|---|---|---|---|---|
|
Left kidney |
174.2 ± 51.7 (123.2;218.7) |
Mean (Gy) |
1.5 ± 1.3 |
(0.1;3.3) |
| |
|
D1cm3 (Gy) |
3.5 ± 3.1 |
(0.1;6.9) |
| |
|
V15Gy (%) |
0.0 ± 0.0 |
(0.0;0.0) |
|
Right kidney |
182.3 ± 37.8 (135.8;213.1) |
Mean (Gy) |
2.8 ± 4.1 |
(0.1;8.8) |
| |
|
D1cm3 (Gy) |
10.6 ± 12.3 |
(0.2;25.1) |
| |
|
V15Gy (%) |
4.1 ± 7.2 |
(0.0;14.8) |
|
Spine |
22.7 ± 7.2 (9.9;35.6) |
D1cm3 (Gy) |
8.2 ± 4.5 |
(1.9;16.7) |
|
Stomach |
174.8 ± 117.2 (76.3;473.2) |
Mean (Gy) |
4.5 ± 3.0 |
(3.0;36.6) |
| |
|
D1cm3 (Gy) |
9.2 ± 5.8 |
(0.3;22.4) |
| |
|
V37.5Gy (%) |
0.0 ± 0.0 |
(0.0;0.0) |
|
Esophagus |
10.3 ± 6.3 (4.8;21.7) |
Mean (Gy) |
5.9 ± 7.9 |
(0.1;19.4) |
| |
|
D1% (Gy) |
10.2 ± 9.7 |
(0.1;30.1) |
| |
|
V50Gy (%) |
0.0 ± 0.0 |
(0.0;0.0) |
|
Liver-PTV |
1242 ± 330 (780;1981) |
Mean (Gy) |
8.6 ± 4.6 |
(1.4;17.1) |
|
(Healthy liver) | ||||
| |
|
V < 15Gy (cm3) |
995.2 ± 163.6 |
(667.6;1718.2) |
| |
|
V30Gy (%) |
24.4 ± 11.6 |
(0.6;56.4) |
|
Total liver |
1439 ± 386 (928;2197) |
Mean (Gy) |
13.3 ± 8.3 |
(2.7;32.9) |
| |
|
V30Gy (%) |
13.8 ± 12.1 |
(1.1;49.3) |
|
Healthy tissue |
20512 ± 5059 (11277;28676) |
Mean (Gy) |
2.5 ± 1.7 |
(0.5;7.3) |
| |
|
V10Gy (%) |
6.1 ± 4.6 |
(0.9;19.5) |
| DoseInt (Gy*cm3*104) | 6.3 ± 2.7 | (0.1;14.2) |
Dx%: dose received by at least x% of the volume; Vx%: volume receiving at least x% of the dose; DoseInt: integral dose.
Data are reported as average values plus or minus standard deviation and range.